JP2002539781A5 - - Google Patents

Download PDF

Info

Publication number
JP2002539781A5
JP2002539781A5 JP2000606725A JP2000606725A JP2002539781A5 JP 2002539781 A5 JP2002539781 A5 JP 2002539781A5 JP 2000606725 A JP2000606725 A JP 2000606725A JP 2000606725 A JP2000606725 A JP 2000606725A JP 2002539781 A5 JP2002539781 A5 JP 2002539781A5
Authority
JP
Japan
Prior art keywords
sequence
gln
lys
gly
cys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000606725A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002539781A (ja
JP4237945B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/006574 external-priority patent/WO2000056866A2/en
Publication of JP2002539781A publication Critical patent/JP2002539781A/ja
Publication of JP2002539781A5 publication Critical patent/JP2002539781A5/ja
Application granted granted Critical
Publication of JP4237945B2 publication Critical patent/JP4237945B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000606725A 1999-03-19 2000-03-14 Akt核酸、ポリペプチドおよびその使用 Expired - Fee Related JP4237945B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12510899P 1999-03-19 1999-03-19
US60/125,108 1999-03-19
PCT/US2000/006574 WO2000056866A2 (en) 1999-03-19 2000-03-14 Akt-3 nucleic acids, polypeptides, and uses thereof

Publications (3)

Publication Number Publication Date
JP2002539781A JP2002539781A (ja) 2002-11-26
JP2002539781A5 true JP2002539781A5 (https=) 2005-04-21
JP4237945B2 JP4237945B2 (ja) 2009-03-11

Family

ID=22418217

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000606725A Expired - Fee Related JP4237945B2 (ja) 1999-03-19 2000-03-14 Akt核酸、ポリペプチドおよびその使用

Country Status (18)

Country Link
EP (1) EP1144600B1 (https=)
JP (1) JP4237945B2 (https=)
KR (1) KR100700908B1 (https=)
AT (1) ATE402995T1 (https=)
AU (1) AU782448B2 (https=)
BR (1) BR0009170A (https=)
CA (1) CA2343074C (https=)
CY (1) CY1108459T1 (https=)
DE (1) DE60039677D1 (https=)
DK (1) DK1144600T3 (https=)
ES (1) ES2310515T3 (https=)
HK (1) HK1041288B (https=)
IL (4) IL141984A0 (https=)
NO (1) NO20014537L (https=)
PT (1) PT1144600E (https=)
SI (1) SI1144600T1 (https=)
WO (1) WO2000056866A2 (https=)
ZA (1) ZA200108414B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881555B2 (en) 1999-03-19 2005-04-19 Aventis Pharmaceuticals Inc. AKT nucleic acids, polypeptides, and uses thereof
MXPA01010459A (es) 1999-04-16 2003-08-20 Univ Yale Mutaciones de sintasa de oxido nitrico endotelial, utiles para terapia con genes y su depuracion terapeutica.
CZ20014444A3 (cs) * 1999-06-11 2002-05-15 Aventis Pharmaceuticals Products Inc. Protein Akt pro pouľití k indukci exprese VEGF
JPWO2003063905A1 (ja) * 2002-01-31 2005-05-26 株式会社東京大学Tlo 免疫疾患の予防又は治療剤
US20060051407A1 (en) * 2003-06-27 2006-03-09 Yoram Richter Method of treating ischemia-reperfusion injury
US10517883B2 (en) 2003-06-27 2019-12-31 Zuli Holdings Ltd. Method of treating acute myocardial infarction
WO2005009470A1 (ja) * 2003-07-28 2005-02-03 Osaka Industrial Promotion Organization Ask1阻害剤を有効成分とする心不全治療薬およびそのスクリーニング方法
WO2009148896A2 (en) * 2008-05-29 2009-12-10 Nuclea Biotechnologies, LLC Anti-phospho-akt antibodies
TWI598347B (zh) 2009-07-13 2017-09-11 基利科學股份有限公司 調節細胞凋亡信號之激酶的抑制劑
NZ604831A (en) 2010-07-02 2014-12-24 Gilead Sciences Inc Apoptosis signal-regulating kinase inhibitors
UY34573A (es) 2012-01-27 2013-06-28 Gilead Sciences Inc Inhibidor de la quinasa que regula la señal de la apoptosis
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
MX2017003933A (es) 2014-09-24 2017-06-30 Gilead Sciences Inc Metodos de tratamiento de la enfermedad hepatica.
CN112225699B (zh) 2014-12-23 2023-11-14 吉利德科学公司 制备ask1抑制剂的方法
MA41252A (fr) 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1
CN113795279B (zh) * 2019-03-04 2024-12-31 宾夕法尼亚州大学信托人 靶向akt通路的神经保护性基因疗法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08109197A (ja) * 1994-10-07 1996-04-30 Sumitomo Electric Ind Ltd 白血病腫瘍拒絶抗原ペプチド
PT862622E (pt) * 1995-11-16 2005-01-31 Novartis Ag Metodo de rastreio para compostos que interagem com proteina cinase rac
US5958773A (en) * 1998-12-17 1999-09-28 Isis Pharmaceuticals Inc. Antisense modulation of AKT-1 expression
GB9828375D0 (en) * 1998-12-22 1999-02-17 Janssen Pharmaceutica Nv Human akt-3
US6043090A (en) * 1999-03-23 2000-03-28 Isis Pharmaceuticals Inc. Antisense inhibition of human Akt-2 expression
WO2000058473A2 (en) * 1999-03-31 2000-10-05 Curagen Corporation Nucleic acids including open reading frames encoding polypeptides; 'orfx'
CZ20014444A3 (cs) * 1999-06-11 2002-05-15 Aventis Pharmaceuticals Products Inc. Protein Akt pro pouľití k indukci exprese VEGF

Similar Documents

Publication Publication Date Title
JP2002539781A5 (https=)
JP5451960B2 (ja) 酵母におけるhpv45l1の最適化された発現
CN115246874B (zh) 一种重组新型冠状病毒s-rbd三聚体蛋白、其制备方法和应用
KR0164215B1 (ko) 사람 유두종바이러스 제16형 e7 단백질상의 면역원성 서열을 갖는 폴리펩타이드
JP2024180560A5 (https=)
WO2022206222A1 (zh) 一种新型冠状病毒s-rbd三聚体蛋白疫苗、其制备方法和应用
CA2343074A1 (en) Akt nucleic acids, polypeptides, and uses thereof
JP2023528204A5 (https=)
CN101062952B (zh) 由人血清白蛋白和干扰素组成的融合蛋白及其编码基因与应用
JP2023522154A5 (https=)
WO2002019965A2 (en) Heat shock response and virus replication
CN106164090B (zh) TRAIL穿膜肽样突变体MuR6、制备方法及应用
US10548973B2 (en) Polypeptide carrier for presenting target polypeptide and uses thereof
JP2024532853A5 (https=)
JP2022542294A5 (https=)
US20090155853A1 (en) Non-viral gene delivery complex
JP2003507029A5 (https=)
US8318662B2 (en) Protein increasing cell infectivity of herpes simplex virus and use thereof
US20260103541A1 (en) Paracrine Adenoviral Delivery of Biomolecules
JPS6312299A (ja) ポリペプチドの生産のための発現ベクタ−、ポリペプチドの交換発現法、発現ベクタ−を含有する宿主、それによりつくられた生産物
CN102643349B (zh) 携带乙肝病毒抗原表位的重组嵌合蛋白及其制备
KR20040097249A (ko) 중공 나노입자를 형성하는 단백질에 질환 치료용 세포도입 물질을 융합시킨 약제
CN117777308A (zh) 基于干扰素协同免疫检查点阻断抗体治疗慢性乙型肝炎
CN1517437B (zh) 特异性治疗肿瘤或胞内感染的疫苗及应用
JP2004518410A5 (https=)